Steven A. Cohen
Steven A. Cohen is a billionaire hedge fund investor and founder of SAC Capital Partners. He has been referred to as "A New Prince of Wall Street" by the New York Times and "The Hedge Fund King" by the Wall Street Journal. According to Forbes, he has an estimated net worth of $6.8 billion.
Cohen attended the Wharton School at the University of Pennsylvania and was hired as a junior trader at Gruntal & Co. in 1978. On his first day, he made an $8,000 profit, and eventually was making around $100,000 a day for the company.
SAC Capital Partners is a hedge fund based in Stamford, Connecticut. It was founded in 1992 by Cohen with $25 million but now currently manages $14 billion. The fund is very active accounting for about 3 percent of the NYSE's daily volume and 1 percent of the NASDAQ's daily volume. The fund's favorite industries include technology, retail/consumer goods, and healthcare.
-
RTI Surgical® Announces Cigna’s Positive Medical Coverage Policy for Minimally Invasive SI Joint Fusion Surgery Using the SImmetry® System
-
RTI Surgical® Announces Cigna’s Positive Medical Coverage Policy for Minimally Invasive SI Joint Fusion Surgery Using the SImmetry® System
-
RTI Surgical® Announces a Centers for Medicare and Medicaid Services’ Physician Payment Increase for Minimally Invasive SI Joint Fusion
-
RTI Surgical® Announces a Centers for Medicare and Medicaid Services’ Physician Payment Increase for Minimally Invasive SI Joint Fusion
-
RTI Surgical® Announces Commercial Launch of the CervAlign® Anterior Cervical Plate System
-
RTI Surgical® Announces Commercial Launch of the CervAlign® Anterior Cervical Plate System
-
RTI Surgical® Reaches 5,000 Implant Milestone for Fortilink® Interbody Fusion Systems with TETRAfuse® 3D Technology
-
RTI Surgical® Reaches 5,000 Implant Milestone for Fortilink® Interbody Fusion Systems with TETRAfuse® 3D Technology
-
RTI Surgical® Wins 2019 MedTech Breakthrough Award for TETRAfuse® 3D Technology
-
RTI Surgical® Wins 2019 MedTech Breakthrough Award for TETRAfuse® 3D Technology
-
RTI Surgical (RTIX) Applauds Blue Cross and Blue Shield of Alabama's Positive Coverage Decision for Minimally Invasive Sacroiliac Joint Fusion Surgery
-
RTI Surgical® Applauds Blue Cross and Blue Shield of Alabama’s Positive Coverage Decision for Minimally Invasive Sacroiliac Joint Fusion Surgery
-
RTI Surgical® Applauds Blue Cross and Blue Shield of Alabama’s Positive Coverage Decision for Minimally Invasive Sacroiliac Joint Fusion Surgery
-
RTI Surgical (RTIX) Reports First Patient Enrollment in FORTE Clinical Study of Fortilink Interbody Fusion Device with TETRAfuse 3D Technology
-
RTI Surgical Enrolls First Patient in FORTE Clinical Study of Fortilink® Interbody Fusion Device with TETRAfuse® 3D Technology
-
RTI Surgical Enrolls First Patient in FORTE Clinical Study of Fortilink® Interbody Fusion Device with TETRAfuse® 3D Technology
